(AUPH) |
| 0 (0%) 04-14 05:02 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 19.06 |
| Resistance 1: | 16.32 |
| Pivot price: | 15.16 |
| Support 1: | 14.77 |
| Support 2: | 13.81 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 2.070 |
| Book Value | 73.200 |
| PEG Ratio | 0.00 |
| Gross Profit | 137031440.000 |
| Profit Margin (%) | 101.46 |
| Operating Margin (%) | 55.68 |
| Return on Assets (ttm) | 11.2 |
| Return on Equity (ttm) | 59.9 |
Company news
Sun, 12 Apr 2026
AUPH - Aurinia Announces Results of Annual General Meeting - ADVFN
Sat, 11 Apr 2026
AUPH stock rallies after CEO shake-up: Retail bulls bet on turnaround - MSN
Fri, 10 Apr 2026
AUPH News | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
Thu, 09 Apr 2026
Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - Sahm
Fri, 03 Apr 2026
Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs - Stock Titan
Mon, 30 Mar 2026
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Business Wire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
